发明名称 SEROTONIN AND CATECHOLAMINE SYSTEM SEGMENT OPTIMIZATION TECHNOLOGY.
摘要 <p>A method of treating neurotransmitter dysfunction in a patient by administering amino acid precursors in conjunction with laboratory assay of the neurotransmitters. The method includes the step of administering an amino acid precursor of a catecholamine in a balanced and effective therapeutic range. The catecholamine precursor is preferably L-dopa, but may alternatively be tyrosine, D,L-Phenylalanine or an active isomer thereof, and N-acetyl-L-tyrosine or other amino acid precursor of L-dopa. An amino acid precursor of serotonin in an effective therapeutic range, is also administered. The serotonin precursor is preferably 5-HTP, but may alternatively be tryptophan. At least one cofactor is also preferably administered. Cofactor options include Vitamin B6, Vitamin C, Calcium, Folate, and Cysteine. A method of periodic administration and patient checking is also disclosed.</p>
申请公布号 MXPA05008943(A) 申请公布日期 2005.11.08
申请号 MX2005PA08943 申请日期 2004.02.23
申请人 MARTIN C. HINZ 发明人 MARTIN C. HINZ
分类号 A61B;A61B1/00;A61K31/198;A61K31/405;G01N33/48;G01N33/53;G01N33/94;(IPC1-7):A61B00/00 主分类号 A61B
代理机构 代理人
主权项
地址